Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
Details for Australian Patent Application No. 2006330072 (hide)
International Classifications
Event Publications
24 July 2008 PCT application entered the National Phase
PCT publication WO2007/075194 Priority application(s): WO2007/075194
2 October 2008 Amendment Made
The nature of the amendment is: Amend the name of the inventor to read Khanna, Ish Kumar; Alexander, Christopher W.; Sreenu, Jennepali; De, Dibyendu; Maitra, Santanu; Pillarisetti, Sivaram; Alikunja, Shanavas and Baruah, Anima
2 October 2008 Alteration of Name
The name of the applicant has been altered to Reddy US Therapeutics, Inc.
16 October 2008 Corrigenda
Amendments - Amendments Made Under the name Reddy US Therapeutics, Inc., Application No. 2006330072, under INID (72), correct the co-inventor names to read Sreenu, Jennepalli and Alikunju, Shanavas
1 April 2010 Assignment before Grant
Reddy US Therapeutics, Inc. The application has been assigned to Dr. Reddy's Laboratories Ltd.
2 August 2012 Application Accepted
Published as AU-B-2006330072
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006330074-System and method for a high reliability base layer trunk
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser